<p>IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma

Published:2020-02 Issue: Volume:Volume 13 Page:1129-1143
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Zhu Chen,Chen Xin,Guan Gefei,Zou Cunyi,Guo Qing,Cheng Peng,Cheng Wen,Wu Anhua

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transcriptional Induction of the Antiviral Host Factor GILT/IFI30 by Interferon Gamma;International Journal of Molecular Sciences;2024-09-06

2. RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity;Frontiers in Immunology;2024-09-06

3. Repurposing Ivermectin and ATRA as Potential Therapeutics for Glioblastoma Multiforme;2024-08-26

4. Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancers;Cellular Oncology;2024-08-14

5. Nudt15-mediated inflammatory signaling contributes to divergent outcomes in leukemogenesis and hematopoiesis;Leukemia;2024-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP